Weizmann Institute

FDA approval

Cop 1 (Copaxone®): The Story of a Drug

Cop 1 (Copaxone®): The Story of a Drug

01.05.1997

Disease, Drugs & Diagnostics

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration

23.12.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee

19.09.1996

Disease, Drugs & Diagnostics

REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...

Top Stories

See All >

brain wave illustration

Firework Memories

ULTRASAT illustration

Next-Gen Israeli Satellite to Seek out Cosmic Explosions and Black Holes

Survival of the Fewest

Sneaky RNA Tag Rendered Visible

Press Releases

See All >

Firework Memories

Next-Gen Israeli Satellite to Seek out Cosmic Explosions and Black Holes

Gut Microbes May Affect the Course of ALS

Most Popular Articles

The Limits of Computing

Computers can solve complex problems but they are far from omnipotent. Prof. Ran Raz of the Weizmann Institute's Computer Science and Applied Mathematics Department is trying to portray the limits...

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.